Ram Halthore
Vice-President, Development

About

Ram Halthore is Vice-President, Development at Kaléo, where he leads device and drug development activities from early design through manufacturing transfer. His responsibilities include developing the company’s human factors engineering programme, leading integrated drug-device product development and overseeing the company’s intellectual property portfolio development.

Mr Halthore has more than 25 years of experience spanning medical devices, pharmaceuticals, biologics and combination products, including autoinjectors, prefilled syringes, inhalation devices, implants and on-body injectors. His prior experience includes leadership roles at Merck, Teva, Amgen, Johnson & Johnson and 3M.

Contributions

INTERVIEW

Interview: Rethinking Drug Delivery for Increasingly Complex Therapies

In this interview, Ram Halthore discusses the demands of newer classes of injectable drugs and the trend towards self-administration using conventional drug delivery systems, the requirements innovative systems must meet and the importance of selecting a delivery system early in formulation development, as well as the roles that robust human factors engineering and high reliability should play in device development.

More contributions

DUAL CHAMBER

GAS-POWERED AUTOINJECTORS: MEETING THE CHALLENGES OF AN EVOLVING DRUG LANDSCAPE

Ram Halthore presents Kaleo's Aerio™ autoinjector platform, discussing how gas-powered autoinjectors have the potential to tackle the challenges currently facing injectable drug delivery, including high-viscosity and large-volume formulations, increased demand for patient-centricity and stringent regulatory requirements for reliability in emergency-use applications.